News: 21 July 2025
For my troubles I have been proofreading the Hawksmoor AIM team’s daily research note a few times last week. They have a couple of defence stocks in there which both reported good results.
News: 08 July 2025
Emerging market debt (EMD) is often seen as a risky asset class however it has changed over the years. Last year I wrote a Market Update on emerging markets (EM) and the reduction in equity volatility vs developed market (DM) equity markets.
News: 30 June 2025
My son Alexander graduated from university recently and has been living with me. We were due to meet up and I was uncharacteristically late, so he sent me a message to say he would get a coffee and wait.
News: 23 June 2025
News: 16 June 2025
Gold has had a significant rally over the past few years. It is often used in portfolios as a diversifier, a hedge against inflation (and more recently against US dollar depreciation), and as a safe haven asset. How investors have accessed the precious metal will have impacted the performance of their portfolios. The two main ways are through bullion or miners.
News: 19 May 2025
News: 28 April 2025
1st quarter earnings season is well underway. The results we’ve had so far have been summarised relatively neatly by the fortunes of two of America’s most famous consumer goods groups, Pepsico and P&G. Each delivered reasonable numbers.
News: 15 April 2025
News: 31 March 2025
Spring has sprung and that means the UK government’s Spring Statement has been released. Like with anything it’s a balancing act and should really offer no surprises after the Autumn Budget.
News: 24 March 2025
Germany passing its new infrastructure and defence spending plans is enormous news. In absolute terms, the EUR500bn that has now been officially approved for infrastructure is not dissimilar to Joe Biden’s (somewhat ironically named) Inflation Reduction Act. However, since the population of Germany is almost equivalent to that of just two of the most populus states (California and Texas) the per capita spend is even more significant.
Sign up here to receive our news, research items or market updates.
